Last update 23 Jan 2025

Schering Plough A/S

Subsidiary Company|
Denmark
|
www.schering-plough.dk

Overview

Related

5
Drugs associated with Schering Plough A/S
NGD-941
Target
D4 receptor
Mechanism
D4 receptor antagonists
Active Org.
Federal University of Rio de JaneiroFederal University of Rio de Janeiro
Originator Org.
Ligand Pharmaceuticals, Inc.Ligand Pharmaceuticals, Inc.
Active Indication
Schizophrenia
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
Nitridocade
Target-
Mechanism
SPECT
Active Org.-
Originator Org.
Schering Plough A/S
Active Indication-
Inactive Indication
Coronary Artery Disease [+1]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
Monoclonal antibody LYM-1-I-131(Northwest University)
Target
CD74
Mechanism
CD74 inhibitors [+1]
Active Org.-
Originator Org.
Northwest UniversityNorthwest University
Active Indication-
Inactive Indication
Non-Hodgkin Lymphoma
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Schering Plough A/S
Login to view more data
0 Patents (Medical) associated with Schering Plough A/S
Login to view more data
100 Deals associated with Schering Plough A/S
Login to view more data
100 Translational Medicine associated with Schering Plough A/S
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 13 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
5
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
NGD-944
 ( D4 receptor )		Schizophrenia
More
Discontinued
Nitridocade
Coronary Artery Disease
More
Discontinued
Monoclonal antibody LYM-1-I-131(Northwest University)
 ( CD74 )		Non-Hodgkin Lymphoma
More
Discontinued
Taltrimide
Epilepsy
More
Discontinued
NGD-941
 ( D4 receptor )		Behavioural disorders
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free